BLX-08155

N/A

Report date: 2025/07/21 16:22:38
NME

Base Information

Drug NameBLX-08155
Drug Alias NameBLX-08155
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiolexis Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiolexis Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A